MACAN WILLIAM ANDREW 4
4 · Neuronetics, Inc. · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Neuronetics (STIM) EVP William A. Macan Sells 3,427 Shares
What Happened
- William A. Macan, EVP, Chief Legal Officer and Corporate Secretary of Neuronetics, sold 3,427 shares on 2026-02-26 in an open-market/private sale. The weighted-average price reported was $1.35 per share for aggregate proceeds of approximately $4,626. This transaction was a sale to satisfy tax withholding related to the vesting of restricted stock units (RSUs), not an opportunistic purchase.
Key Details
- Transaction date: 2026-02-26; Form 4 filed: 2026-02-27.
- Shares sold: 3,427; weighted-average price: $1.35; price range across trades: $1.38 to $1.31; proceeds ≈ $4,626.
- Reason: Non-discretionary sales to satisfy tax withholding upon RSU vesting (footnote F1).
- Footnote F2: price is a weighted-average; the filer can provide the number of shares sold at each price within the $1.31–$1.38 range on request.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Timeliness: Filing appears timely (transaction date 2/26/2026, filed 2/27/2026).
Context
- Sales to cover tax withholding on vested RSUs are common and typically procedural rather than a market-sentiment signal. No purchase, option exercise, or 10b5-1 plan is indicated in the filing excerpt.
Insider Transaction Report
Form 4
MACAN WILLIAM ANDREW
EVP, CLO and CS
Transactions
- Sale
Common Stock
[F1][F2]2026-02-26$1.35/sh−3,427$4,626→ 880,134 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Patrick Devine, as Attorney-in-Fact|2026-02-27